Clinical Study on A Unani Formulation in Management of Ziabetus Shakari (Diabetes Mellitus Type 2)

Abstract

A randomized single blind standard controlled study was designed to evaluate the efficacy of a Unani formulation, in the treatment of diabetes mellitus type 2 (DMT2). Forty diagnosed patient of DMT2 randomly allocated to Group A (Test) and Group B (Control) comprising 20 patient each. Group A was given test drug in the dose of 3 gm twice daily where as patients of Group B were given Diabecon 2 tablet orally twice daily for 45 days. The study reveals that the test drug exhibited significant effect on subjective parameters like polyuria and progressive weakness (p<0.05), in polydipsia and unexplained weight loss (p<0.01), and in tiredness (p<0.001); while there was no effect in polyphagia (p>0.05). On objective parameters there was significant effect observed on urine sugar (p<0.01) and HbA1c (p<0.05), while there was no significant effect found on FBS and PPBS (p>0.05).